ProfileGDS4132 / 220918_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 57% 61% 54% 60% 53% 60% 55% 45% 65% 62% 70% 71% 60% 55% 77% 76% 63% 72% 77% 66% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101158.52957
GSM201543Muscle PCOS pioglitazone 121162.56461
GSM201544Muscle PCOS pioglitazone 161148.67754
GSM201545Muscle PCOS pioglitazone 201176.58860
GSM201829Muscle PCOS pioglitazone 231151.76553
GSM201830Muscle PCOS pioglitazon 251174.90460
GSM201831Muscle PCOS pioglitazone 271155.66455
GSM201832Muscle PCOS pioglitazone 31117.98245
GSM201833Muscle PCOS pioglitazone 41176.13665
GSM201834Muscle PCOS pioglitazone 81171.68662
GSM201835Muscle PCOS after pioglitazone 102201.62370
GSM201836Muscle PCOS after pioglitazone 122208.83271
GSM201837Muscle PCOS after pioglitazone 162151.01860
GSM201838Muscle PCOS after pioglitazone 202140.90855
GSM201839Muscle PCOS after pioglitazone 232258.36177
GSM201840Muscle PCOS after pioglitazone 252256.88676
GSM201841Muscle PCOS after pioglitazone 272166.66363
GSM201842Muscle PCOS after pioglitazone 32197.65772
GSM201843Muscle PCOS after pioglitazone 42251.70177
GSM201844Muscle PCOS after pioglitazone 82192.47266